HomeClinical TopicsFDA requires safety labeling changes for fluoroquinolones

FDA requires safety labeling changes for fluoroquinolones

Author(s):

On July 10, the U.S. Food and Drug Administration (FDA) announced safety labeling changes for fluoroquinolones, including stronger warnings about risks of mental health disturbances and hypoglycemic coma.

Read more via FDA.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

NP taking pregnant woman's blood pressure

AHA: It’s Safe to Treat High Blood Pressure During Pregnancy

High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...